Market data including bonds and fuel prices
The unskilled workforce in particular will be affected by the steps the country will be compelled to take
A former senior investigator who worked closely with the public protector on the report accused her of watering it down and removing portions
The premier announced her cabinet after a meeting with the ANC’s deployment committee and its alliance partners
Business Day TV speaks to African Rail Industry Association CEO Mesela Nhlapo
Credit bureau sees more defaults ahead as central bank increases interest rates
The improved sentiment is a result of increased merchandise export and import volumes and more new vehicles sold, Sacci report says
Soldiers say they killed scores of attackers during hours-long bombardment that included drones, car bombs and artillery in southern Mali
Top swimmers have a rivalry that could develop into one of SA sport’s greatestt
The Italian SUV outguns the Bentley Bentayga's record
Jerusalem — The Pfizer-BioNTech vaccine is highly effective against the delta variant of Covid-19, a Pfizer official in Israel said on Thursday.
First identified in India, delta is becoming the globally dominant version of the coronavirus, according to the World Health Organisation (WHO).
“The data we have today, accumulating from research we are conducting at the lab and including data from those places where the Indian variant, delta, has replaced the British variant as the common variant, point to our vaccine being very effective, around 90%, in preventing the coronavirus disease, Covid-19,” Alon Rappaport, Pfizer's medical director in Israel, told local broadcaster Army Radio.
A spokesperson for Pfizer did not immediately respond to a request for comment when asked to provide further details.
Israel, with one of the world’s most advanced vaccination campaigns largely based on the Pfizer-BioNTech shot, still lacks enough data to provide insight into vaccine effectiveness against the delta variant, said Sharon Alroy-Preis, head of public health at Israel’s health ministry.
“We are collecting the data now. We are only now seeing the first cases of the delta variant in Israel — about 200 of those — so we will know more soon,” she told reporters on Wednesday.
An analysis by Public Health England (PHE), where the delta variant is more widespread, found that both the Pfizer-BioNTech and AstraZeneca vaccines provide more than 90% protection against hospitalisation from the delta variant.
In Israel, more than half the 9.3-million population has received both Pfizer shots and a steep drop in cases has prompted most economic restrictions to be lifted.
But confirmed cases have risen in the past few days and health authorities have urged parents to vaccinate their 12-to 15-year-olds, who were made eligible earlier in June.
Alroy-Preis said about 65% of Israel’s population was protected against Covid-19, either by vaccination or by recovering from the disease, a figure she said was still far from providing “herd immunity.”
Would you like to comment on this article? Register (it's quick and free) or sign in now.
Please read our Comment Policy before commenting.
Published by Arena Holdings and distributed with the Financial Mail on the last Thursday of every month except December and January.